文献速递主动脉疾病

1998年至2020年英格兰胸主动脉瘤住院、干预及死亡率趋势:一项观察性研究

Trends in Thoracic Aortic Aneurysm Hospital Admissions, Interventions, and Mortality in England between 1998 and 2020: An Observational Study.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2022-07-13

该观察性研究分析1998至2020年英格兰胸主动脉瘤住院、干预及动脉瘤相关死亡率趋势,并比较血管内修复时代前后死亡率变化。结果显示非破裂胸主动脉瘤住院率上升,干预增加主要因TEVAR增加,男性和女性动脉瘤相关死亡率均下降,80岁以上破裂性疾病女性死亡率降幅最大。

要点

  • 非破裂胸主动脉瘤住院率从1998年4.11/10万升至2020年12.61/10万。
  • TEVAR从2006年0.26/10万增至2020年2.15/10万,是干预增加主因。
  • 血管内修复时代男性和女性动脉瘤相关死亡率均下降,80岁以上破裂性疾病女性降幅最大。

核心结论

  • 过去23年英格兰非破裂胸主动脉瘤住院显著增加,同时转向血管内修复,动脉瘤相关死亡率不论性别和年龄均显著下降。
  • 血管内修复时代破裂和非破裂胸主动脉瘤年龄标化死亡率显著下降,尤其是80岁以上破裂性疾病女性,证实血管内方法对胸主动脉瘤的积极影响。

研究设计与样本

  • 观察性研究,分析1998至2020年英格兰胸主动脉瘤住院、手术方式(TEVAR或开放手术)及动脉瘤相关死亡率数据。
  • 住院和手术方式数据来自医院统计(Hospital Episodes Statistics),动脉瘤相关死亡率数据来自英格兰国家统计局,标化至2013年欧洲标准人口。
  • 采用线性回归和Joinpoint回归分析,比较血管内修复前时代(1998-2008)与血管内修复时代(2009-2019)的动脉瘤相关死亡率。

主要发现

  • 非破裂胸主动脉瘤住院发生率从1998年4.11/10万(95%CI 3.71-4.50)升至2020年12.61/10万(95%CI 12.00-13.21),r²=.98,p<.001。
  • TEVAR从2006年0.26/10万(95%CI 0.16-0.36)增至2020年2.15/10万(95%CI 1.91-2.41),r²=.90,p<.001。
  • 男性和女性动脉瘤相关死亡率均下降,不论年龄和破裂状态。
  • 血管内修复时代动脉瘤相关死亡率最大降幅见于80岁以上破裂性疾病女性(15.26/10万 vs 9.50/10万,p<.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess trends in thoracic aortic aneurysm (TAA) hospital admissions, interventions, and aneurysm related mortality (ARM) in England, and examine the impact of endovascular repair on mortality for the years 1998 to 2020. METHODS: Hospital admission and operative approach (thoracic endovascular aortic repair, [TEVAR] or open surgical repair) using Hospital Episodes Statistics, and ARM data from the Office for National Statistics for England standardised to the 2013 European Standard Population were analysed using linear regression and Joinpoint regression analyses. ARM was compared between the pre-endovascular era (1998 - 2008) and the endovascular era (2009 - 2019). RESULTS: A rising trend in hospital admission incidence has been observed, mainly due non-ruptured admissions (4.11 per 100 000 in 1998; 95% confidence interval (CI) 3.71 - 4.50 to 12.61 per 100 000 in 2020; 95% CI 12.00 - 13.21 in 2020; r2 = .98; p < .001). Operative interventions increased mainly due to an increase in TEVAR (2.15 per 100 000; 95% CI 1.91 - 2.41 in 2020 vs. 0.26 per 100 000; 95% CI 0.16 - 0.36 in 2006; r2 = .90; p < .001). Reductions in ARM from TAA were observed for males and females, irrespective of age and rupture status. The greatest reduction in ARM in the endovascular era was observed in females aged > 80 years with ruptured disease (15.26 deaths per 100 000 vs. 9.50 deaths per 100 000; p < .001). CONCLUSION: A significant increase in hospital admissions for non-ruptured TAA has been observed in the last 23 years in England, paralleled by a shift towards endovascular repair, and significant declining trends in ARM, irrespective of sex and age. The significant reductions in age standardised death rates from ruptured and non-ruptured TAA in the endovascular era, particularly for females aged > 80 years with ruptured disease, affirm the positive impact of an endovascular approach to TAA.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Hanna L, Sounderajah V, Abdullah AA, et al. Trends in Thoracic Aortic Aneurysm Hospital Admissions, Interventions, and Mortality in England between 1998 and 2020: An Observational Study. Eur J Vasc Endovasc Surg. 2022. PMID: 35842176. doi:10.1016/j.ejvs.2022.07.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。